Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today.
Net sales declined 12% year-over-year to $10.1 billion.
Net earnings decreased 48% to $1 billion while EPS fell 47% to $0.59. Adjusted earnings were down 23% to $1.8 billion while adjusted EPS dropped 22% to $1.03.
Abbott expects adjusted EPS from continuing operations to be $4.30-4.50 for the full year of 2023.
Aramark Holdings Corp (NYSE: ARMK) shares closed at about $38.77 on Monday, marking a modest…
S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…
Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…
Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…
CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…
Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…